Newbridge Financial Services Group, Inc. 180 Life Sciences Corp. Transaction History

Newbridge Financial Services Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$0.81 - $2.53 $2,430 - $7,589	-3,000 Reduced 85.71%	500 $0
Q4 2021 Jan 19, 2022	BUY	$3.27 - $6.38 $1,635 - $3,190	500 Added 16.67%	3,500 $14,000
Q2 2021 Sep 07, 2021	BUY	$6.7 - $11.98 $20,100 - $35,940	3,000 New	3,000 $30,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $88.6M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.